Lombard Odier Asset Management (Switzerland) Sa Y M Abs Therapeutics, Inc. Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.14 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$13.96 - $19.67 $169,446 - $238,754	-12,138 Reduced 6.71%	168,795 $2.43 Million
Q2 2022 Aug 15, 2022	SELL	$8.22 - $15.13 $335,713 - $617,924	-40,841 Reduced 18.42%	180,933 $2.74 Million
Q1 2022 May 16, 2022	SELL	$6.55 - $17.42 $1.07 Million - $2.85 Million	-163,666 Reduced 42.46%	221,774 $2.64 Million
Q4 2021 Feb 14, 2022	BUY	$15.51 - $29.31 $505,641 - $955,535	32,601 Added 9.24%	385,440 $6.25 Million
Q3 2021 Nov 12, 2021	BUY	$27.47 - $37.31 $901,208 - $1.22 Million	32,807 Added 10.25%	352,839 $10.1 Million
Q2 2021 Aug 13, 2021	BUY	$25.45 - $37.64 $3.53 Million - $5.21 Million	138,540 Added 76.33%	320,032 $10.8 Million
Q1 2021 May 17, 2021	BUY	$29.16 - $51.96 $5.29 Million - $9.43 Million	181,492 New	181,492 $5.49 Million

Others Institutions Holding YMAB

# of Institutions

106

Shares Held

24.5M

Call Options Held

40.3K

Put Options Held

400

Paradigm Biocapital Advisors LP New York, NY

4.09M
Shares

$45.5 Million
1.93% of portfolio
Black Rock Inc. New York, NY

2.94M
Shares

$32.7 Million
0.0% of portfolio
Sofinnova Investments, Inc. Menlo Park, CA

2.19M
Shares

$24.4 Million
2.73% of portfolio
Vanguard Group Inc Valley Forge, PA

2.04M
Shares

$22.7 Million
0.0% of portfolio
Polar Capital Holdings PLC London, X0

1.83M
Shares

$20.4 Million
0.15% of portfolio

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account